• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

涉及白细胞介素5和嗜酸性粒细胞的移植排斥非经典途径的证据。

Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils.

作者信息

Martinez O M, Ascher N L, Ferrell L, Villanueva J, Lake J, Roberts J P, Krams S M

机构信息

Department of Surgery, University of California, San Francisco 94143.

出版信息

Transplantation. 1993 Apr;55(4):909-18. doi: 10.1097/00007890-199304000-00041.

DOI:10.1097/00007890-199304000-00041
PMID:8475567
Abstract

The role of IL-5 and eosinophils in allograft rejection was studied in human liver allograft recipients. Liver allograft biopsies were analyzed for intragraft IL-5 gene expression, and the percentages of eosinophils and plasma cells within the portal infiltrate as well as peripheral eosinophil levels were determined. The majority of allografts with evidence of rejection had concomitant IL-5 mRNA and eosinophilia, while no resolving or nonrejecting allografts had simultaneous IL-5 mRNA and eosinophilia. In fact, rejecting liver allografts that contain IL-5 mRNA and eosinophils also contain infiltrating cells that produce the cytotoxic mediator major basic protein. In contrast, intragraft plasma cell and peripheral eosinophil levels did not correlate with the histopathologic status of the allograft. Cyclosporine and FK506 had similar effects on the frequency of IL-5 gene expression in rejecting and nonrejecting allografts. However, OKT3 appeared to profoundly modulate IL-5 gene expression, since 0 of 11 biopsies obtained during OKT3 treatment for rejection contained IL-5 transcripts. These observations raise the possibility of a cellular pathway of liver allograft rejection mediated by IL-5-activated eosinophils.

摘要

在人类肝移植受者中研究了白细胞介素-5(IL-5)和嗜酸性粒细胞在同种异体移植排斥反应中的作用。对肝移植活检组织进行分析,检测移植物内IL-5基因表达情况,并测定门管区浸润中嗜酸性粒细胞和浆细胞的百分比以及外周血嗜酸性粒细胞水平。大多数有排斥反应证据的移植物同时存在IL-5信使核糖核酸(mRNA)和嗜酸性粒细胞增多,而正在恢复或无排斥反应的移植物均未同时出现IL-5 mRNA和嗜酸性粒细胞增多。事实上,含有IL-5 mRNA和嗜酸性粒细胞的正在排斥的肝移植物中还含有产生细胞毒性介质主要碱性蛋白的浸润细胞。相比之下,移植物内浆细胞水平和外周血嗜酸性粒细胞水平与移植物的组织病理学状态无关。环孢素和他克莫司(FK506)对正在排斥和未排斥的移植物中IL-5基因表达频率的影响相似。然而,OKT3似乎能显著调节IL-5基因表达,因为在接受OKT3治疗排斥反应期间获取的11份活检组织中,有0份含有IL-5转录本。这些观察结果提示存在一条由IL-5激活的嗜酸性粒细胞介导的肝移植排斥反应细胞途径。

相似文献

1
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils.涉及白细胞介素5和嗜酸性粒细胞的移植排斥非经典途径的证据。
Transplantation. 1993 Apr;55(4):909-18. doi: 10.1097/00007890-199304000-00041.
2
IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro.肝移植受者体内及体外对同种异体抗原应答时白细胞介素-2和白细胞介素-5的基因表达
Transplantation. 1993 May;55(5):1159-66. doi: 10.1097/00007890-199305000-00042.
3
The eosinophil as an effector cell of the immune response during hepatic allograft rejection.嗜酸性粒细胞作为肝移植排斥反应中免疫应答的效应细胞。
Hepatology. 1994 Sep;20(3):654-62. doi: 10.1016/0270-9139(94)90102-3.
4
Intragraft cytokine profile during human liver allograft rejection.
Transplantation. 1992 Feb;53(2):449-56. doi: 10.1097/00007890-199202010-00035.
5
Eosinophil cationic protein's role in human hepatic allograft rejection.
Hepatology. 1991 Jun;13(6):1117-25.
6
Elevated biliary interleukin 5 as an indicator of liver allograft rejection.胆汁中白细胞介素5升高作为肝移植排斥反应的指标。
Transpl Immunol. 1995 Dec;3(4):291-8. doi: 10.1016/0966-3274(95)80014-x.
7
Eosinophils in acute renal allograft rejection.
Transpl Immunol. 1994;2(1):41-6. doi: 10.1016/0966-3274(94)90076-0.
8
Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.白细胞介素-9促进小鼠心脏同种异体移植的嗜酸性排斥反应。
Transplantation. 2003 Aug 15;76(3):572-7. doi: 10.1097/01.TP.0000071201.32424.D2.
9
Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection.移植物内嗜酸性粒细胞增多和白细胞介素-5信使核糖核酸与肝移植排斥反应相伴发生。
Transplant Proc. 1993 Feb;25(1 Pt 1):126-7.
10
Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection.移植肝内白细胞介素-4信使核糖核酸的表达与肝移植排斥反应的下调有关。
Clin Transplant. 1996 Dec;10(6 Pt 1):542-9.

引用本文的文献

1
Programmed T cell differentiation: Implications for transplantation.程序性 T 细胞分化:对移植的影响。
Cell Immunol. 2020 May;351:104099. doi: 10.1016/j.cellimm.2020.104099. Epub 2020 Mar 29.
2
Eosinophils promote inducible NOS-mediated lung allograft acceptance.嗜酸性粒细胞促进诱导型一氧化氮合酶介导的肺移植接受。
JCI Insight. 2017 Dec 21;2(24):96455. doi: 10.1172/jci.insight.96455.
3
Innate immune cells in liver inflammation.肝脏炎症中的固有免疫细胞。
Mediators Inflamm. 2012;2012:949157. doi: 10.1155/2012/949157. Epub 2012 Aug 9.
4
Innate immunity and resistance to tolerogenesis in allotransplantation.同种异体移植中的固有免疫与耐受生成抵抗。
Front Immunol. 2012 Apr 19;3:73. doi: 10.3389/fimmu.2012.00073. eCollection 2012.
5
IL-6 promotes cardiac graft rejection mediated by CD4+ cells.白细胞介素-6 通过 CD4+细胞促进心脏移植物排斥反应。
J Immunol. 2011 Dec 1;187(11):5764-71. doi: 10.4049/jimmunol.1100766. Epub 2011 Oct 24.
6
Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.中和小鼠白细胞介素-17的生物活性可抑制角膜移植排斥反应。
Mol Vis. 2011;17:2148-56. Epub 2011 Aug 11.
7
Sequential evolution of IL-17 responses in the early period of allograft rejection.同种异体移植排斥反应早期 IL-17 反应的序贯演变。
Exp Mol Med. 2009 Oct 31;41(10):707-16. doi: 10.3858/emm.2009.41.10.077.
8
Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells.抗CD4与抗CD40L治疗后的移植接受情况:移植物反应性T细胞差异维持的证据
Am J Transplant. 2008 Oct;8(10):2037-48. doi: 10.1111/j.1600-6143.2008.02372.x.
9
CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.CD8+ Th17细胞在T-bet缺陷小鼠中介导共刺激阻断抗性同种异体移植排斥反应。
J Immunol. 2008 Sep 15;181(6):3906-14. doi: 10.4049/jimmunol.181.6.3906.
10
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.白细胞介素-4、白细胞介素-5和嗜酸性粒细胞在慢性皮肤同种异体移植排斥反应中的关键作用。
J Clin Invest. 1999 Jun;103(12):1659-67. doi: 10.1172/JCI5504.